Latest Articles
CIGC’s LAAM Procedure: A Proven Solution for Fibroid Treatment and Fertility Enhancement - The Malaysian Reserve
CIGC’s LAAM Procedure: A Proven Solution for Fibroid Treatment and Fertility Enhancement The Malaysian Reserve
Published: Oct. 15, 2024, 8:46 p.m.
‘It feel like a long road ahead’: NI woman shares her health journey which saw her being placed in a medically-induced menopause - Belfast Telegraph
‘It feel like a long road ahead’: NI woman shares her health journey which saw her being placed in a medically-induced menopause Belfast Telegraph
Published: Oct. 15, 2024, 8 a.m.
Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases - ScienceDirect.com
Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases ScienceDirect.com
Published: July 15, 2024, 7 a.m.
Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer - OncLive
Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer OncLive
Published: July 1, 2024, 7 a.m.
'Affected Me Very Personally' – Danielle Collins Reveals Sickening Battle Alongside Endometriosis That She Was Forced to Endure - EssentiallySports
'Affected Me Very Personally' – Danielle Collins Reveals Sickening Battle Alongside Endometriosis That She Was Forced to Endure EssentiallySports
Published: July 1, 2024, 7 a.m.
Isha Ambani says she had twins through IVF: What are myths about the procedure that need to be busted? - The Indian Express
Isha Ambani says she had twins through IVF: What are myths about the procedure that need to be busted? The Indian Express
Published: June 29, 2024, 7 a.m.
Offering cutting-edge care for endometriosis and fertility at Burjeel Medical City’s Advanced Gynecology Institute - Gulf News
Offering cutting-edge care for endometriosis and fertility at Burjeel Medical City’s Advanced Gynecology Institute Gulf News
Published: June 28, 2024, 7 a.m.
Dostarlimab/Chemotherapy Under EMA Review for Primary Advanced/Recurrent Endometrial Cancer - OncLive
Dostarlimab/Chemotherapy Under EMA Review for Primary Advanced/Recurrent Endometrial Cancer OncLive
Published: June 24, 2024, 7 a.m.
FDA approves Keytruda plus chemo for primary advanced, recurrent endometrial carcinoma - Medical Xpress
FDA approves Keytruda plus chemo for primary advanced, recurrent endometrial carcinoma Medical Xpress
Published: June 24, 2024, 7 a.m.
Lenvatinib/Pembrolizumab Misses OS End Points, But Still Shows Activity, in Advanced Endometrial Cancer - OncLive
Lenvatinib/Pembrolizumab Misses OS End Points, But Still Shows Activity, in Advanced Endometrial Cancer OncLive
Published: June 21, 2024, 7 a.m.
Link copied to clipboard!